Transcriptional activation of the insulin-like growth factor I receptor gene by the Kruppel-like factor 6 (KLF6) tumor suppressor protein: Potential interactions between KLF6 and p53

Endocrinology

Volumn 145, Issue 8, 2004, Pages 3769-3777

  Rubinstein, Moran ^a   Idelman, Gila ^a   Plymate, Stephen R ^b   Narla, Goutham ^c   Friedman, Scott L ^c   Werner, Haim ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF WASHINGTON   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 6; PROTEIN P53; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL LEVEL; COLORECTAL CANCER; CONTROLLED STUDY; DROSOPHILA; GENE ACTIVATION; GENE DELETION; HUMAN; HUMAN CELL; INSECT CELL; MALE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REACTION ANALYSIS; RECEPTOR GENE; REPORTER GENE; TRANSACTIVATION; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

ANIMALS; CHO CELLS; CRICETINAE; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; RECEPTOR, IGF TYPE 1; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 3843050225     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0173     Document Type: Article

References (42)

1. LeRoith D, Werner H, Beitner-Johnson D, Roberts Jr CT 1995 Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16: 143-163
2. Baserga R, Hongo A, Rubini M, Frisco M, Valentinis B 1997 The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta 1332:F105-F126
3. Werner H, Le Roith D 1997 The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis. Crit Rev Oncog 8:71-92
4. Tennant MK, Thrasher JB, Twomey PA, Drivdahl RH, Birnbaum RS, Plymate SR 1996 Protein and mRNA for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium. J Clin Endocrinol Metab 81:3774-3782
5. Kaplan PJ, Mohan S, Cohen P, Foster BA, Greenberg NM 1999 The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model. Cancer Res 59:2203-2209
6. Chott A, Sun Z, Morganstern D, Pan J, Li T, Susani M, Mosberger I, Upton MP, Bubley GJ, Balk SP 1999 Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of type 1 insulin-like growth factor receptor. Am J Pathol 155:1271-1279
7. Hellawell GO, Turner GD, Davies DR, Poulsom R, Brewster SF, Macaulay VM 2002 Expression of the type 1 insulin-like growth factor receptor is upregulated in primary prostate cancer and commonly persists in metastatic disease. Cancer Res 62:2942-2950
8. Werner H, Stannard B, Bach MA, LeRoith D, Roberts Jr CT 1990 Cloning and characterization of the proximal promoter region of the rat insulin-like growth factor I (IGF-I) receptor gene. Biochem Biophys Res Comm 169:1021-1027
9. Cooke DW, Bankert LA, Roberts Jr CT, LeRoith D, Casella SJ 1991 Analysis of the human type I insulin-like growth factor receptor promoter region. Biochem Biophys Res Commun 177:1113-1120
10. Smale ST, Baltimore D1989 The "initiator" as a transcription control element. Cell 57:103-113
11. Black AR, Black JD, Azizkhan-Clifford J 2001 Sp1 and Kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 188:143-160
12. Beitner-Johnson D, Werner H, Roberts Jr CT, LeRoith D 1995 Regulation of insulin-like growth factor I receptor gene expression by Sp1: physical and functional interactions of Sp1 at GC boxes and at a CT element. Mol Endocrinol 9:1147-1156
13. Werner H, Bach MA, Stannard B, Roberts Jr CT, LeRoith D 1992 Structural and functional analysis of the insulin-like growth factor I receptor gene promoter. Mol Endocrinol 6:1545-1558
14. Koritschoner NP, Bocco JL, Panzetta-Dutari GM, Dumur CI, Flury A, Patrito LC 1997 A novel human zinc finger protein that interacts with the core promoter element of a TATA box-less gene. J Biol Chem 272:9573-9580
15. Ratziu V, Lalazar A, Wong L, Dang Q, Collins C, Shaulian E, Jensen S, Friedman SL 1998 Zf9, a Kruppel-like transcription factor up-regulated in vivo during early hepatic fibrosis. Proc Natl Acad Sci USA 95:9500-9505
16. Trybus TM, Burgess AC, Wojno KJ, Glover TW, Macoska JA 1996 Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer. Cancer Res 56:2263-2267
17. Ittmann M 1996 Allelic loss on chromosome 10 in prostate adenocarcinoma. Cancer Res 56:2143-2147
18. Narla G, Heath KE, Reeves HL, Li D, Giono LE, Kimmelman AC, Glucksman MJ, Narla J, Eng FJ, Chan AM, Ferrari AC, Martignetti JA, Friedman SL 2001 KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science 294:2563-2566
19. Vax VV, Gueorguiev M, Dedov II, Grossman AB, Korbonits M 2003 The Kruppel-like transcription factor 6 gene in sporadic pituitary tumours. Endocrine Relat Cancer 10:397-402
20. Chen HK, Liu XQ, Lin J, Chen TY, Feng QS, Zeng YX 2002 Mutation analysis of KLF6 gene in human nasopharyngeal carcinomas. Ai Zheng 21:1047-1050
21. Jeng Y-M, Hsu H-C 2003 KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas. Int J Cancer 105:625-629
22. Reeves HL, Narla G, Ogunbiyi O, Haq AI, Katz A, Benzeno S, Hod E, Harpaz N, Goldberg S, Tal-Kremer S, Eng FJ, Arthur MJP, Martignetti JA, Friedman SL 2004 Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer. Gastroenterology 126:1090-1103
23. Okano J, Opitz OG, Nakagawa H, Jenkins TD, Friedman SL, Rustgi AK 2000 The Kruppel-like transcriptional factors Zf9 and GKLF coactivate the human keratin 4 promoter and physically interact. FEBS Lett 473:95-100
24. Kim Y, Ratziu V, Choi S-G, Lalazar A, Theiss G, Dang Q, Kim S-J, Friedman SL 1998 Transcriptional activation of transforming growth factor β1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1. J Biol Chem 273:33750-33758
25. Yasuda K, Hirayoshi K, Hirata H, Kubota H, Hosokawa N, Nagata K 2002 The Kruppel-like factor Zf9 and proteins in the Sp1 family regulate the expression of HSP47, a collagen-specific molecular chaperone. J Biol Chem 277:44613-44622
26. Warke VG, Nambiar MP, Krishnan S, Tenbrock K, Geller DA, Koritschoner NP, Atkins JL, Farber DL, Tsokos GC 2003 Transcriptional activation of the human inducible nitric-oxide synthase promoter by Kruppel-like factor 6. J Biol Chem 278:14812-14819
27. Botella LM, Sanchez-Elsner T, Sanz-Rodriguez F, Kojima S, Shimada J, Guerrero-Esteo M, Cooreman MP, Ratziu V, Langa C, Vary CPH, Ramirez JR, Friedman SL, Bernabeu C 2002 Transcriptional activation of endoglin and transforming growth factor-β signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury. Blood 100:4001-4010
28. Bae VL, Jackson-Cook CK, Maygarden SJ, Plymate SR, Chen J, Ware JL 1998 Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line. Prostate 34:275-282
29. 2 arrest after DNA damage. Science 282:1497-1501
30. Werner H, Rauscher III FJ, Sukhatme VP, Drummond IA, Roberts Jr CT, LeRoith D 1994 Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site. J Biol Chem 269:12577-12582
31. Marin MC, Jost CA, Irwin MS, DeCaprio JA, Caput D, Kaelin WG 1998 Viral oncoproteins discriminate between p53 and the p53 homolog p73. Mol Cell Biol 18:6316-6324
32. Werner H, Roberts Jr CT 2003 The IGF-I receptor gene: a molecular target for disrupted transcription factors. Genes Chromosomes Cancer 36:113-120
33. Damon SE, Plymate SR, Carroll JM, Sprenger CC, Dechsukhum C, Ware JL, Roberts Jr CT 2001 Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells. Endocrinology 142:21-27
34. Abramovitch S, Glaser T, Ouchi T, Werner H 2003 BRCA1-Sp1 interactions in transcriptional regulation of the IGF-IR gene. FEBS Lett 541:149-154
35. Nickerson T, Chang F, Lorimer D, Smeekens SP, Sawyers CL, Pollak M 2001 In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR). Cancer Res 61:6276-6280
36. Chen C, Hyytinen E-R, Sun X, Helin HJ, Koivisto PA, Frierson Jr HF, Vessella RL, Dong J-T 2003 Deletion, mutation, and loss of expression of KLF6 in human prostate cancer. Am J Pathol 162:1349-1354
37. Narla G, Friedman SL, Martignetti JA 2003 Kruppel cripples prostate cancer: KLF6 progress and prospects. Am J Pathol 162:1047-1052
38. Yamashita K, Upadhyay S, Osada M, Hoque MO, Xiao Y, Mori M, Sato F, Meltzer SJ, Sidransky D 2002 Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2:485-495
39. Werner H, Karnieli E, Rauscher III FJ, LeRoith D 1996 Wild type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc Natl Acad Sci USA 93:8318-8323
40. Idelman G, Glaser T, Roberts Jr CT, Werner H 2003 WT1-p53 interactions in IGF-I receptor gene regulation. J Biol Chem 278:3474-3482
41. Abramovitch S, Werner H 2003 Functional and physical interactions between BRCA1 and p53 in transcriptional regulation of the IGF-IR gene. Horm Metab Res 35:758-762
42. Ohlsson C, Kley N, Werner H, LeRoith D 1998 p53 regulates IGF-I receptor expression and IGF-I induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and Sp1. Endocrinology 139:1101-1107